
Magnetic Resonance Microsensors Corporation (AKA: MRM~Protesis) Profile last edited on: 1/6/06
CAGE:
UEI:
Business Identifier: NO Business Identifier is currently available for this company. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 13
County: Champaign
Congr. District: 13
County: Champaign
Public Profile
In 2001, the firm was acquired by MA based Protesis. The firm now operates as Magnetic Resonance Microsensors (MRM), an operating unit of Protasis Corporation, is the leading maker of capillary-based, microliter-volume probes for NMR spectroscopy. These new-to-market devices rely on microcoil technology and offer fast, sensitive performance and downscaled sample handling capability. Founded by an interdisciplinary group of chemists, NMR spectroscopists and engineers from the Beckman Institute at the University of Illinois, MRM was formed expressly to develop and bring to market microcoil (sub-microliter volume) NMR detection technology. MRM has focused its research efforts on developing a family of specialized microcoil-based probes designed specifically for compatibility with the Waters CapLC. As a result, MRM probes now offer a 10-fold sensitivity gain when compared to conventional NMR probes and present exciting new opportunities for NMR application to capillary-based analytical systems. NMR analysis is rapidly growing as an information-rich technique for determining structural information for synthetic and natural product chemistry research. Yet, a recurring problem that restricts the versatility of this technology is the difficulties associated with effective, automated management of the sample. To the satisfaction of a growing list of customers, MRM has solved this problem by purifying and concentrating sample peaks using Waters CapLC and then parking them in sensitive, flexible and convenient MRM CapNMR Probes. MRM's mission is the commercialization of microcoil (sub-microliter volume) nuclear magnetic resonance (NMR) detection technology developed in the Beckman Institute and patented by the University of Illinois. This technology enables at very small scales (sub-microliter volumes) the characterization and identification of chemical compounds. This process is of high interest to pharmaceutical, biotechnology, and chemical products companies, for research and development, manufacture, and quality control.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2006 | 2 | NIH | $921,635 | |
Project Title: Multi-microcoil Probes for Capillary Scale NMR Detection | ||||
2002 | 2 | NIH | $1,205,187 | |
Project Title: Microcoil-Based Probes For Capillary LC-NMR Detection | ||||
1998 | 2 | NIH | $849,997 | |
Project Title: Microcoil Based Probes for Nanoliter Volume NMR | ||||
1996 | 1 | NIH | $99,567 | |
Project Title: Microlithographic Probe for Cellular Level NMR Detection | ||||
1995 | 1 | NSF | $100,000 | |
Project Title: Analytical Microseparations with Nuclear Magnetic Resonance Detection |
Key People / Management
Tim Peck -- President
Company News
There are no news available.